NextGen Healthcare, Inc.

NasdaqGS:NXGN Stock Report

Market Cap: US$1.6b

NextGen Healthcare Past Earnings Performance

Past criteria checks 0/6

NextGen Healthcare's earnings have been declining at an average annual rate of -27.3%, while the Healthcare Services industry saw earnings growing at 1.8% annually. Revenues have been growing at an average rate of 5.3% per year.

Key information

-27.3%

Earnings growth rate

-28.3%

EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth rate5.3%
Return on equity-1.5%
Net Margin-0.9%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?

Aug 24
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 27
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist

Jul 13
Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Jun 08
We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)

May 19
Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)

What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?

Mar 14
What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Feb 27
We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value

Dec 08
Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value

These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong

Oct 27
These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong

At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?

Sep 30
At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?

NextGen Enterprise solution to be used by NY-based health center

Sep 28

NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price

Sep 07
NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price

NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital

Jul 29
NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital

NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates

Jul 26

Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?

May 17
Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?

NextGen At A Crossroads

Oct 13

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?

Jun 29
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?

Revenue & Expenses Breakdown

How NextGen Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqGS:NXGN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23695-619479
30 Jun 23678218581
31 Mar 23653-318682
31 Dec 226262318982
30 Sep 226142019181
30 Jun 22604019979
31 Mar 22596219877
31 Dec 21589119879
30 Sep 21581-420077
30 Jun 215721319077
31 Mar 215571018276
31 Dec 20549617676
30 Sep 205451017077
30 Jun 20539516779
31 Mar 20540716683
31 Dec 195391616682
30 Sep 195321616482
30 Jun 195282316881
31 Mar 195292416481
31 Dec 185301017382
30 Sep 18531617582
30 Jun 18533117383
31 Mar 18531219381
31 Dec 175281816982
30 Sep 175242716581
30 Jun 175182316280
31 Mar 175101815978
31 Dec 16505-215872
30 Sep 16494-615867
30 Jun 16493-115767
31 Mar 16492615666
31 Dec 154933315667
30 Sep 154993215871
30 Jun 154942915970
31 Mar 154902715669
31 Dec 144772215467
30 Sep 14462315061
30 Jun 14453815052
31 Mar 144451614942
31 Dec 13441614735
30 Sep 134463514629
30 Jun 134514014528
31 Mar 134604314831
31 Dec 124586214432

Quality Earnings: NXGN is currently unprofitable.

Growing Profit Margin: NXGN is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: NXGN is unprofitable, and losses have increased over the past 5 years at a rate of 27.3% per year.

Accelerating Growth: Unable to compare NXGN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NXGN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (41.2%).

Return on Equity

High ROE: NXGN has a negative Return on Equity (-1.47%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/11 09:24
End of Day Share Price 2023/11/08 00:00
Earnings2023/09/30
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NextGen Healthcare, Inc. is covered by 38 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew GillmorBaird
Ishan MajumdarBaptista Research
K. JuhngBB&T Capital Markets